Our people

programmes, focusing on bringing the evidence to life in practice. He is passionate about the potential for global-regional-local scientific communication and exchange to help support evidence-based decision-making, and to deliver improved patient care alongside improved industry engagement, transparency and reputation. Charlie holds an MBA from Lancaster Management School, specialising in strategy development, intervening in complex organisations and systems, and managing change in practice. As an advocate of pharma’s role in scientific communication and healthcare provision, Charlie has presented at numerous industry conferences and authored several articles in well reputed journals, including the Journal of Medical Marketing and the BMJ. Often these have focused on the activation of evidence in clinical practice, or on the need for a more balanced and open debate about the role of industry as a stakeholder in healthcare provision.

healthcare communications, she has worked in many project types with a variety of domestic and global clients across a wide range of therapy areas. She has also seen huge changes in how we go about the day-to-day business of medical communications and publication planning, becoming a Certified Medical Publications Professional in 2010. She is an active ISMPP committee member (currently serving on the Issues & Actions committee).
Jackie’s logical approach to problem-solving and project development is one of her key strengths, and her Operations role encompasses the development of standard operating procedures both within the editorial team and across disciplines to ensure the understanding of and adherence to ethical and compliance guidelines, quality control protocols, as well as processes that contribute to the smooth and efficient development of projects.

experience with a clinical research organization, provides clients with a unique understanding of the drug development and communications continuum. Her experience includes pharmaceutical, biotechnology and device client companies and her focus has included the integration of strategic publication planning, key expert relationships, and disease state education via multi-media communication channels.
Her inclusive leadership style and recognition that ‘this is a team effort’, has also enabled her to gain the respect of and foster long lasting relationships with colleagues. While some may not welcome the ongoing changes in this industry, Janet embraces change in order to grow, be innovative and remain passionate about her role as a medical communications professional.